|
|
|
Insider
Information: |
Column Group Ii Gp, Lp |
Relationship: |
10% Owner |
City: |
San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
800,000 |
|
Indirect Shares
|
1,000 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$1,540 |
|
|
Total
Shares |
801,000 |
|
|
Total
Value |
$1,540 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
59
|
0
|
Stock
price went up :
|
24
|
0
|
Stock
price went down : |
35
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-3.1%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Immune Design Corp. |
IMDZ |
10% Owner |
2016-09-20 |
800,000 |
|
0 |
Premium* |
|
Ngm Biopharmaceuticals Inc |
NGM |
10% Owner |
2024-04-05 |
0 |
2024-04-05 |
1,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
78 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NGM |
Ngm Biopharmaceuticals In... |
General Partner |
|
2020-04-07 |
4 |
B |
$14.38 |
$1,779,209 |
D/D |
123,728 |
1,427,469 |
2.45 |
% |
|
NGM |
Ngm Biopharmaceuticals In... |
General Partner |
|
2020-03-23 |
4 |
B |
$11.63 |
$1,981,601 |
D/D |
170,387 |
907,377 |
2.45 |
% |
|
NGM |
Ngm Biopharmaceuticals In... |
General Partner |
|
2022-06-09 |
4 |
B |
$13.50 |
$13,286,174 |
I/I |
984,161 |
90,442 |
1.5 |
% |
|
78 Records found
|
|
Page 4 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|